{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:53:21Z","timestamp":1791327201163,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180868"],"award-info":[{"award-number":["U10CA180868"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180822"],"award-info":[{"award-number":["U10CA180822"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UG1CA189867"],"award-info":[{"award-number":["UG1CA189867"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA196067"],"award-info":[{"award-number":["U24CA196067"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijrobp.2026.09.014","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:14:37Z","timestamp":1790896477000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High SMAD4 Expression is Associated with Improved Clinical Outcomes in Patients with Resectable Pancreatic Cancer: An Analysis of NRG Oncology\/RTOG 9704"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1020-0845","authenticated-orcid":false,"given":"Terence M","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Moughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F","family":"Regine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia D","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A","family":"DiPetrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C","family":"Leasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree E","family":"Doncals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E","family":"Henke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guila","family":"Delouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Haddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Ben-Josef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.09.014_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0002","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the united states","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer research"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0003","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: A review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0004","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0005","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The lap07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0006","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An eastern cooperative oncology group trial","volume":"29","author":"Loehrer","year":"2011","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0007","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Results of the dutch randomized phase iii preopanc trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0008","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7150\/ijbs.23230","article-title":"The role of tgf-beta\/smad4 signaling in cancer","volume":"14","author":"Zhao","year":"2018","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0009","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"Ryan","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0010","article-title":"Cancer Genome Atlas Research N. Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0011","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0013","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"Dpc4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer","volume":"27","author":"Iacobuzio-Donahue","year":"2009","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0014","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1158\/1078-0432.CCR-09-0227","article-title":"Smad4 gene mutations are associated with poor prognosis in pancreatic cancer","volume":"15","author":"Blackford","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tranon.2015.11.007","article-title":"Prognostic value of smad4 in pancreatic cancer: A meta-analysis","volume":"9","author":"Shugang","year":"2016","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0016","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MPA.0000000000000985","article-title":"Smad4 loss correlates with higher rates of local and distant failure in pancreatic adenocarcinoma patients receiving adjuvant chemoradiation","volume":"47","author":"Herman","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0017","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1002\/cncr.33038","article-title":"Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma","volume":"126","author":"McIntyre","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0018","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.299.9.1019","article-title":"Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial","volume":"299","author":"Regine","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0019","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/1078-0432.CCR-20-1422","article-title":"Altered gemcitabine and nab-paclitaxel scheduling improves therapeutic efficacy compared with standard concurrent treatment in preclinical models of pancreatic cancer","volume":"27","author":"Wolfe","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"Journal of the American Statistical Association"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0021","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0022","unstructured":"Kalbfleisch JD, Prentice, R.L. The statistical analysis of failure time data. New York, John Wiley & Sons 1980:167-169."},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0023","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of k-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"The Annals of Statistics"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0024","doi-asserted-by":"crossref","unstructured":"Cox DR. Regression models and life-tables. Journal of the Royal Statistical Society, Series B 1972;34:187-202.","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"Journal of the American Statistical Association"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0026","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.12.042","article-title":"Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia","volume":"142","author":"Kanda","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0027","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc.2016.66","article-title":"Pancreatic cancer biology and genetics from an evolutionary perspective","volume":"16","author":"Makohon-Moore","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3420","article-title":"Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma","volume":"4","author":"Qian","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0029","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/modpathol.2008.62","article-title":"Expression of smad2 and smad4 in cervical cancer: Absent nuclear smad4 expression correlates with poor survival","volume":"21","author":"Kloth","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0030","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/his.13805","article-title":"Smad4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer","volume":"74","author":"Oyanagi","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0031","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0032","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12957-015-0502-0","article-title":"Clinical outcome and expression of mutant p53, p16, and smad4 in lung adenocarcinoma: A prospective study","volume":"13","author":"Bian","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0033","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3748\/wjg.v22.i9.2678","article-title":"Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells","volume":"22","author":"Nielsen","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0034","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","article-title":"Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts","volume":"67","author":"Zeisberg","year":"2007","journal-title":"Cancer research"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.canep.2010.10.002","article-title":"Structural and functional analysis of smad4 gene promoter in malignant pancreatic and colorectal tissues: Detection of two novel polymorphic nucleotide repeats","volume":"35","author":"Nikolic","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0036","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1158\/1078-0432.CCR-06-1467","article-title":"Inactivation of smad4 tumor suppressor gene during gastric carcinoma progression","volume":"13","author":"Wang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0037","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","article-title":"Dpc4, a candidate tumor suppressor gene at human chromosome 18q21.1","volume":"271","author":"Hahn","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0038","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.3748\/wjg.v9.i12.2764","article-title":"Loss of dpc4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma","volume":"9","author":"Hua","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0039","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1101\/gad.1478706","article-title":"Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer","volume":"20","author":"Bardeesy","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2007.01.017","article-title":"Kras(g12d) and smad4\/dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas","volume":"11","author":"Izeradjene","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0041","first-page":"4115","article-title":"The smad4 protein and prognosis of pancreatic ductal adenocarcinoma","volume":"7","author":"Tascilar","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0042","article-title":"Rhot1 and smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancer","volume":"7","author":"Jiang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0043","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.gassur.2005.06.021","article-title":"Vascular endothelial growth factor and dpc4 predict adjuvant therapy outcomes in resected pancreatic cancer","volume":"9","author":"Khorana","year":"2005","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0044","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/SLA.0b013e3182827a65","article-title":"Immunohistochemically detected expression of 3 major genes (cdkn2a\/p16, tp53, and smad4\/dpc4) strongly predicts survival in patients with resectable pancreatic cancer","volume":"258","author":"Oshima","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MPA.0b013e318247d6af","article-title":"Smad4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma","volume":"41","author":"Singh","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0046","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jso.23606","article-title":"Loss of smad4 staining in pre-operative cell blocks is associated with distant metastases following pancreaticoduodenectomy with venous resection for pancreatic cancer","volume":"110","author":"Boone","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0047","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jamasurg.2013.2690","article-title":"Locally advanced pancreatic cancer: Association between prolonged preoperative treatment and lymph-node negativity and overall survival","volume":"149","author":"Kadera","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0048","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1200\/JCO.2010.33.8038","article-title":"Phase ii trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (t4) pancreatic adenocarcinoma: Correlation of smad4(dpc4) immunostaining with pattern of disease progression","volume":"29","author":"Crane","year":"2011","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0049","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijrobp.2017.10.030","article-title":"Prognostic value of c-met expression in patients with pancreatic cancer receiving adjuvant and neoadjuvant chemoradiation therapy","volume":"100","author":"Cuneo","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.09.014_bib0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","article-title":"Molecular subtypes of pancreatic cancer","volume":"16","author":"Collisson","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626043105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626043105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:33:40Z","timestamp":1791326020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626043105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S0360301626043105"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.09.014","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High SMAD4 Expression is Associated with Improved Clinical Outcomes in Patients with Resectable Pancreatic Cancer: An Analysis of NRG Oncology\/RTOG 9704","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}